Minocycline Extended-Release Tablets and Moxetumomab pasudotox
Determining the interaction of Minocycline Extended-Release Tablets and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: minocycline
Brand name: Dynacin, Minocin, Minocin PAC, Minolira, Solodyn, Ximino, Vectrin, Myrac
Synonyms: Minocycline, Minocycline (Systemic)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Minocycline Extended-Release Tablets-Moxetumomab Pasudotox-tdfk
- Minocycline Extended-Release Tablets-Moxetumomab pasudotox-tdfk Intravenous
- Minocycline Extended-Release Tablets-Moxifloxacin
- Minocycline Extended-Release Tablets-Moxifloxacin (Systemic)
- Minocycline Extended-Release Tablets-Moxifloxacin Hydrochloride
- Minocycline Extended-Release Tablets-Moxifloxacin Injection
- Moxetumomab pasudotox-Minocycline Hydrochloride
- Moxetumomab pasudotox-Minocycline Hydrochloride eent
- Moxetumomab pasudotox-Minocycline Hydrochloride Periodontal Microspheres
- Moxetumomab pasudotox-Minocycline Injection
- Moxetumomab pasudotox-Minocycline Intravenous
- Moxetumomab pasudotox-Minocycline mucous membrane powder